Name : PARK9/ATP13A2 Antibody, FITC Conjugated
Supplier : BIOSS PRIMARY CONJUGATED ANTIBODIES 1
Price :333
SKU : GEN6383613211
| Long name | FITC Conjugated, PARK9/ATP13A2 Polyclonal Antibody |
| Category | Conjugated Primary Antibodies |
| Conjugation | Anti-FITC Antibody |
| Host Organism | Rabbit (Oryctolagus cuniculus) |
| Target Antigen | PARK9/ATP13A2 |
| Specificity | This is a highly specific antibody against PARK9/ATP13A2 |
| Modification | Unmodified |
| Modification site | None |
| Clonality | Polyclonal |
| Clone | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Subcellular location | Extracellular |
| Source | KLH conjugated synthetic peptide derived from human ATP13A2 |
| Tested applications | IF(IHC-P) |
| Recommended dilutions | IF(IHC-P)(1:50-200) |
| Crossreactivity | Mouse, Rat, Human |
| Crossreactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Antigen background | ATP13A2 functions to catalyze the conversion of ATP to ADP and a free phosphate, Defects in the gene encoding ATP13A2 are the cause of Kufor-Rakeb syndrome (KRS), Expressed as multiple alternative spliced isoforms, The ATP13A2 gene maps to human chromosome 1, a rare hereditary type of Parkinsonâ, contains over 3, thereby participating in the active transport of ions across cellular membranes, which spans 260 million base pairs, &euro, &trade, 000 genes and comprises nearly 8% of the human genome, 180 amino acid multi-pass membrane protein that belongs to the P5 subfamily of ATPases which play an important role in the transportation of inorganic cations, ATP13A2 is a 1, s disease that exhibits juvenile onset and is characterized by neurodegeneration and dementia |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Excitation Emission | 494nm/518nm |
| Synonyms | HSA9947 CLN12 |
| Properties | Bioss Primary Conjugated Antibodies FITC is highly sensitive to pH extremes, FITC has a green emission that's usually collected at 530 nanometers, FITC has a high quantum yield (efficiency of energy transfer from absorption to emission fluorescence) and approximately half of the absorbed photons are emitted as fluorescent light, For fluorescent microscopy applications, This Bioss Primary Conjugated Antibodies Fluorescein isothiocyanate (FITC) antibody is currently after some BD antibodies the most commonly used fluorescent dye for FACS, When excited at 488 nanometers, its photo bleaching effects are not observed due to a very brief interaction at the laser intercept, the 1 FITC is seldom used as it photo bleaches rather quickly though in flow cytometry applications, the FL1 detector of a FACSCalibur or FACScan, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Gene target | PARK9/ATP13A2 Conjugated |
| Short name | FITC Conjugated, PARK9/ATP13A2 Antibody |
| Technique | Fluorescein, antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label | FITC |
| Alternative name | fluorecein coupled, PARK9/ATP13A2 (Antibody to) |
| Alternative technique | antibodies |
| Identity | 30213 |
| Gene | ATP13A2 |
| Long gene name | ATPase 13A2 |
| Synonyms gene | PARK9 |
| Synonyms gene name | Parkinson disease (autosomal recessive) 9 (Kufor-Rakeb syndrome) ATPase type 13A2 |
| Locus | 1p36, 13 |
| Discovery year | 2005-01-12 |
| GenBank acession | AL354615 |
| Entrez gene record | 23400 |
| Pubmed identfication | 15381061 16964263 |
| RefSeq identity | NM_022089 |
| Classification | Parkinson disease associated genes ATPase orphan transporters |
| Havana BLAST/BLAT | OTTHUMG00000002293 |
| Locus Specific Databases | LRG_834 |